Sign inGet started

Shook David

Insider CIK 1959742 · NKTX See Remarks · LYEL Chief Medical Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
LYEL Lyell Immunopharma, Inc. S Sale2026-09-102026-09-10500$12.70 $6.3K20,423SEC↗
LYEL Lyell Immunopharma, Inc. S Sale2026-09-102026-09-10500$12.70 $6.3K20,423SEC↗
LYEL Lyell Immunopharma, Inc. S Sale2026-06-102026-06-111,977$12.64 $25.0K20,923SEC↗
LYEL Lyell Immunopharma, Inc. A Award deriv2026-02-102026-02-1150,000— $050,000SEC↗
LYEL Lyell Immunopharma, Inc. A Award deriv2025-06-092025-06-1143,750— $043,750SEC↗
LYEL Lyell Immunopharma, Inc. A Award2025-06-092025-06-1121,900— $021,900SEC↗
NKTX Nkarta, Inc. S Sale2025-01-152025-01-178,638$2.20 $19.0K190,955SEC↗
NKTX Nkarta, Inc. A Award deriv2025-01-032025-01-07117,500— $0117,500SEC↗
NKTX Nkarta, Inc. A Award2025-01-032025-01-0759,000— $0199,593SEC↗
NKTX Nkarta, Inc. A Award2024-08-212024-08-231,352$5.11 $6.9K138,593SEC↗
NKTX Nkarta, Inc. A Award deriv2024-07-152024-07-3130,000— $030,000SEC↗
NKTX Nkarta, Inc. A Award2024-07-152024-07-3123,421— $0139,945SEC↗
NKTX Nkarta, Inc. S Sale2024-06-182024-06-20456$5.60 $2.6K116,524SEC↗
NKTX Nkarta, Inc. S Sale2024-01-162024-01-183,552$8.74 $31.0K114,980SEC↗
NKTX Nkarta, Inc. A Award deriv2024-01-042024-01-08112,500— $0112,500SEC↗
NKTX Nkarta, Inc. A Award2024-01-042024-01-0856,000— $0118,532SEC↗
NKTX Nkarta, Inc. S Sale2023-08-212023-08-231,331$1.83 $2.4K60,532SEC↗
NKTX Nkarta, Inc. A Award deriv2023-07-012023-07-05208,000— $0208,000SEC↗
NKTX Nkarta, Inc. S Sale2023-06-202023-06-22439$4.85 $2.1K61,863SEC↗
NKTX Nkarta, Inc. S Sale2023-01-172023-01-18175$5.49 $96160,302SEC↗
NKTX Nkarta, Inc. A Award deriv2023-01-132023-01-1875,000— $075,000SEC↗
NKTX Nkarta, Inc. A Award2023-01-132023-01-1837,500— $060,477SEC↗